70 related articles for article (PubMed ID: 14514712)
21. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.
Koyama N; Yamazaki T; Kanetsuki Y; Hirota J; Asai T; Mitsumoto Y; Mizuno M; Shima T; Kanbara Y; Arai S; Miyazaki T; Okanoue T
J Gastroenterol; 2018 Jun; 53(6):770-779. PubMed ID: 29086016
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.
Zhang X; Pan C; Zhou L; Cai Z; Zhao S; Yu D
BMC Cancer; 2016 Dec; 16(1):949. PubMed ID: 27986075
[TBL] [Abstract][Full Text] [Related]
24. Glycosylation: a hallmark of cancer?
Vajaria BN; Patel PS
Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
[TBL] [Abstract][Full Text] [Related]
25. ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway.
Chen X; Wang L; Zhao Y; Yuan S; Wu Q; Zhu X; Niang B; Wang S; Zhang J
Oncotarget; 2016 Aug; 7(32):51955-51964. PubMed ID: 27340870
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma.
Wu H; Shi XL; Zhang HJ; Song QJ; Yang XB; Hu WD; Mei GL; Chen X; Mao QS; Chen Z
Onco Targets Ther; 2016; 9():2227-36. PubMed ID: 27143918
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel plasma glycosylation-associated markers of aging.
Catera M; Borelli V; Malagolini N; Chiricolo M; Venturi G; Reis CA; Osorio H; Abruzzo PM; Capri M; Monti D; Ostan R; Franceschi C; Dall'Olio F
Oncotarget; 2016 Feb; 7(7):7455-68. PubMed ID: 26840264
[TBL] [Abstract][Full Text] [Related]
28. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.
Nie H; Liu X; Zhang Y; Li T; Zhan C; Huo W; He A; Yao Y; Jin Y; Qu Y; Sun XL; Li Y
Sci Rep; 2015 Nov; 5():16007. PubMed ID: 26537865
[TBL] [Abstract][Full Text] [Related]
29. Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
Lu J; Gu J
Molecules; 2015 Apr; 20(5):7509-27. PubMed ID: 25919275
[TBL] [Abstract][Full Text] [Related]
30. Expression of ST3Gal, ST6Gal, ST6GalNAc and ST8Sia in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02.
Zhang Y; Zhao W; Zhao Y; He Q
Glycoconj J; 2015 Feb; 32(1-2):39-47. PubMed ID: 25572164
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.
Biswas S; Medina SH; Barchi JJ
Carbohydr Res; 2015 Mar; 405():93-101. PubMed ID: 25556664
[TBL] [Abstract][Full Text] [Related]
32. Salivary glyco-sialylation changes monitors oral carcinogenesis.
Vajaria BN; Patel KR; Begum R; Patel JB; Shah FD; Joshi GM; Patel PS
Glycoconj J; 2014 Dec; 31(9):649-59. PubMed ID: 25318700
[TBL] [Abstract][Full Text] [Related]
33. α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes.
Wang S; Chen X; Wei A; Yu X; Niang B; Zhang J
Tumour Biol; 2015 Feb; 36(2):885-92. PubMed ID: 25304155
[TBL] [Abstract][Full Text] [Related]
34. Serum sialic acids levels according to the severity of liver cirrhosis.
Chrostek L; Supronowicz L; Panasiuk A; Cylwik B; Gruszewska E; Szmitkowski M
J Clin Lab Anal; 2014 Nov; 28(6):465-8. PubMed ID: 24659250
[TBL] [Abstract][Full Text] [Related]
35. The expression of essential components for human influenza virus internalisation in Vero and MDCK cells.
Ugiyadi M; Tan MI; Giri-Rachman EA; Zuhairi FR; Sumarsono SH
Cytotechnology; 2014 May; 66(3):515-23. PubMed ID: 23912187
[TBL] [Abstract][Full Text] [Related]
36. Defining putative glycan cancer biomarkers by MS.
Mechref Y; Hu Y; Garcia A; Zhou S; Desantos-Garcia JL; Hussein A
Bioanalysis; 2012 Oct; 4(20):2457-69. PubMed ID: 23157355
[TBL] [Abstract][Full Text] [Related]
37. Identifying cancer biomarkers by mass spectrometry-based glycomics.
Mechref Y; Hu Y; Garcia A; Hussein A
Electrophoresis; 2012 Jul; 33(12):1755-67. PubMed ID: 22740464
[TBL] [Abstract][Full Text] [Related]
38. Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins.
Alley WR; Novotny MV
J Proteome Res; 2010 Jun; 9(6):3062-72. PubMed ID: 20345175
[TBL] [Abstract][Full Text] [Related]
39. Differences in the sialylation patterns of membrane stress proteins in chemical carcinogen-induced tumors developed in BALB/c and IL-1alpha deficient mice.
Avidan A; Perlmutter M; Tal S; Oraki O; Kapp T; Krelin Y; Elkabets M; Dotan S; Apte RN; Lichtenstein RG
Glycoconj J; 2009 Dec; 26(9):1181-95. PubMed ID: 19430902
[TBL] [Abstract][Full Text] [Related]
40. Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.
Shah MH; Telang SD; Shah PM; Patel PS
Glycoconj J; 2008 Apr; 25(3):279-90. PubMed ID: 18158621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
